Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use

Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use

Self-assembling nanoparticles (SANPs) promise an effective delivery of bisphosphonates or microRNAs in the treatment of glioblastoma (GBM) and are obtained through the sequential mixing of four components immediately before use. The self-assembling approach facilitates technology transfer, but the c...

Full description

Bibliographic Details
Main Authors: Abate, M. (Author), Biondi, M. (Author), Campani, V. (Author), Caraglia, M. (Author), De Rosa, G. (Author), Leonetti, C. (Author), Nele, V. (Author), Porru, M. (Author), Scotti, L. (Author), Zappavigna, S. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
bisphosphonates
differential scanning calorimetry
glioblastoma
lyophilization
scale-up
self-assembling nanoparticles
zoledronic acid
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items